Avid Bioservices Inc (CDMO): Entdoc... I do agree that there is less...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	85
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: entdoc post# 125971

Tuesday, 06/04/2013 11:35:40 AM

Tuesday, June 04, 2013 11:35:40 AM

Entdoc... I do agree that there is less and less of that going on. I was only picking on Pfizer because they are the largest BP... biggest market cap close to $200B and I'd have to say that Pfizer would clearly be looking into Peregrine if they want to remain in that #1 rating for the longterm and can't see them passing up on Bavituximab.

Its not just for a single indication... and like any large BP... Bavi combines well on the safety side... and "IF" Peregrine is revealilng any of the "betabodie" data to an interested BP

I can't see them passing up on Peregrine.

May historic data... bring us historic market caps.

GLTA!

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!